RGF® first developed its Photohydroionization® (PHI-CELL®) technology over 20 years ago and since then more than four million units have been installed worldwide. Over the years the PHI-Cell evolved into the REME-HALO® and now the widely popular HALO-LED™.
RGF® has licensed its technology to many Fortune 500 companies for use in health care, food processing, military, government, marine, hospitality, residential and commercial applications. In addition, RGF®’s PHI-Cell technology has been specified in the Norovirus and MRSA protection plan of America’s largest restaurant chains, hotel chains, theme parks, cruise lines and public school.
Below you will find a summary of some of the testing and studies performed by third party independent labs and universities. While the research is compelling, RGF® PHI-Cell products are not medical devices and no medical claims are made.
Testing Summary: 99+% – SARS – Severe Acute Respiratory Syndrome
SARS, Severe acute respiratory syndrome is a viral respiratory illness caused by a coronavirus, called SARS-associated coronavirus (SARS-VoV). SARS was first reported in Asia in February 2003. Over the next few months, the illness spread to more than two dozen countries in North America, South America, Europe, and Asia before the SARS global outbreak of 2003 was contained. The main way SARS seems to spread is by close person-to-person contact. The disease can spread when droplets from the cough or sneeze of an infected person are propelled a short distance (generally up to 3 feet) through the air. The virus also can spread when a person touches a surface or object contaminated with the infectious droplets and then touches his or her mouth, nose or eye(s).
Source: CDC: Center for Disease Control and Prevention
Tested by NEI Chinese Government – 99+% inactivation rate